Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus, heart failure, and chronic kidney disease. It lowers blood glucose by increasing urinary glucose excretion and provides proven cardiovascular and renal benefits. Empagliflozin API is produced under GMP standards and is suitable for oral tablet formulations.

Empagliflozin API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.